Blog
Notes from inside the build.
What I am seeing in pharma, AI, and the work of building things people actually use.
Pharma, AI
The 6 Pharma Field Force Workflows That Should Already Be Automated in 2026
Pharma reps spend 72% of the week not selling. McKinsey says 75-85% of workflows can now be automated. Here are the 6 field force workflows ready to ship in 2026.
Jun 16 · 3 min read
AI
Your Pharma Has Six AI Vendors. Here Is How to Get to One.
Your mid-size pharma runs six AI vendors. Six contracts, six governance regimes, six audit trails. Here is the 16-week consolidation pattern to one unified agent layer.
Jun 15 · 3 min read
Business, Pharma, AI
Channel-Agnostic Loyalty: Why the Retail Pharmacy Owns Your Customer, Not You
Your brand sells through retail. The retailer owns the customer data. Private label is at record share. Here is the channel-agnostic loyalty platform that closes the gap.
Jun 14 · 3 min read
AI
How a Single AI Content System Produces a Week of Pharma LinkedIn Content in 4 Hours
You are a pharma leader who should be visible on LinkedIn. You do not have time. Here is the AI content system that produces a week of research-backed content in 4 hours.
Jun 13 · 3 min read
AI
Pharma Reps Forget Most of Launch Training Within 30 Days. Here Is the L&D System That Fixes It.
Pharma reps forget up to 80% of launch training within 30 days. Here is the spaced-repetition L&D system that fixes it, and what a 30-day pilot looks like in your org.
Jun 12 · 3 min read
AI
The AI Agent Architecture Every Pharma Will Eventually Build. Here Is the Blueprint.
Every pharma over 500 people will eventually build an AI agent layer. The architecture is converging on the same six components. Here is the blueprint and how I deploy it.
Jun 11 · 3 min read
AI
3 Reasons Your Pharma AI Pilot Is Stuck in PowerPoint (And the 90-Day Path Out)
Two-thirds of organizations are stuck in AI pilot mode. 95% of pharma AI pilots never deliver business value. Here are the three reasons yours is one of them, and the 90-day plan that gets you out.
Jun 10 · 3 min read
AI
Your Pharma Has 5,000 Target Doctors and 30 Field Reps. Here Is the Fix.
Your field force can cover 60 to 80 doctors a month. Your brand needs to reach hundreds more. Here is the AI doctor engagement system that closes the gap and the pilot that proves it in 7 days.
Jun 9 · 3 min read
AI
Your Pharma Is Losing 21 Days on Every Cross-Functional Decision. Here Is How to Stop It.
Every cross-functional decision inside your pharma is routing through five to twelve stakeholders, and the math on that cascade adds twenty-one days to your timeline before anyone has actually disagreed
Jun 8 · 3 min read
Pharma, AI
Why Generative AI in Pharma Marketing Will Trigger the Next FDA Wave
In 2025, the FDA issued over two hundred enforcement letters challenging prescription drug advertising, the highest annual total in nearly twenty-five years
May 29 · 3 min read
Pharma, AI
Why Mid-Size Pharma Will Lose the AI Race
Eli Lilly is building a one-billion-dollar AI supercomputer with Nvidia. Johnson & Johnson, Roche, Pfizer, and Novo Nordisk have direct partnerships with the four largest AI infrastructure providers in the world.
May 28 · 3 min read
Pharma, AI
AI in Pharmacovigilance: The 18-Month Window
Pharmacovigilance is the function where the volume math has already broken. Manual processing cannot scale. AI is forced, not optional.
May 26 · 3 min read
Pharma, AI, Business
Pharma Boards Are Approving AI They Don't Understand
Pharma boards are signing off on billion-dollar AI commitments while two-thirds of directors admit they have limited or no AI knowledge.
May 25 · 3 min read
Pharma, Business, AI
What the EU AI Act Means for Pharma
Most of the AI a pharma company is currently building lands in the high-risk tier of the EU AI Act by default.
May 24 · 3 min read
Pharma, AI
The Real Cost of a Failed Pharma AI Pilot
The average sunk cost of an abandoned enterprise AI project is 7.2 million dollars. The pharma-specific picture is worse. 95 percent of pharma AI pilots fail to reach production.
May 23 · 3 min read
Pharma, AI
The Audit Trail Problem: Why Pharma's AI Deployments Will Face FDA Scrutiny by 2027
The FDA issued 40 untitled letters in a single day in September 2025. The next enforcement wave will target AI-driven decisions without audit trails. Here is why your pharma company needs to act now.
May 11 · 3 min read
AI, Pharma
Why Pharma's Best AI Bets Are Boring (And Why That's the Point)
The AI investments that will define pharma's next decade are not the flashy ones. They are the boring ones. Here is what to look for and why your CFO will not approve them.
May 10 · 3 min read
AI, Business, Pharma
How to Brief an AI Agent Like a Senior Partner: A Pharma Operator's Framework
Most pharma teams brief AI agents like search engines. The teams getting results brief them like senior associates. Here is the framework that changes the output.
May 6 · 3 min read
Pharma, AI
Why I Built Human in the Loop for Pharma
Pharma leaders make hundreds of decisions a week with no audit trail. Human in the Loop is the AI deployment model that makes pharma accountable.
Apr 29 · 3 min read
Pharma, AI
AI in Pharma Is an Architecture Decision, Not a Procurement One
Most pharma boardrooms ask which AI model to buy. The companies winning are asking which architecture to build. Here is why that matters.
Apr 8 · 3 min read
Pharma, AI
Pharma Spends $6.2B on HCP Marketing. 97% Gets Ignored.
Pharma spent 6.2 billion dollars on HCP digital marketing in 2025. 97 percent of it got ignored. Here is the data and what actually works.
Apr 1 · 3 min read
Get new posts in your inbox.
No spam. No funnel sequences. Just new writing when it ships.
Unsubscribe anytime. Your email is never sold.